Cumin (Black Cumin / Kalonji) for Cholesterol Management

Research suggests that black cumin (Nigella sativa) may support improvements in cholesterol profiles, with multiple studies reporting reductions in LDL cholesterol and triglycerides alongside increases in HDL cholesterol in supplemented groups. The available evidence includes a small randomized controlled trial and several other controlled studies, many of which focused on specific populations such as patients with Hashimoto's thyroiditis or used animal models, and the majority of findings point in a supportive direction. Studies indicate that thymoquinone, an active compound in black cumin, may contribute to these lipid-related effects, potentially through antioxidant and anti-inflammatory mechanisms, though one study examined its effects in the context of Alzheimer's-related research in rats rather than cholesterol management directly. Limitations across this body of evidence are notable — sample sizes are generally small, several studies involve animal models whose findings may not translate directly to humans, and the field would benefit from larger and more rigorously designed human trials before firm conclusions can be drawn.